What is included in this Sample?
- * Market Segmentation
- * Key Findings
- * Research Scope
- * Table of Content
- * Report Structure
- * Report Methodology
Download FREE Sample Report
Balloon Aortic Valvuloplasty Devices Market Size, Share, Growth and Industry Analysis, By Type (Balloon Diameter (mm) 18-22, Balloon Diameter (mm) 22-25, Balloon Diameter (mm) 25-28, Others), By Application (Old Man, Middle-aged Person, Youth and Children), Regional Insights and Forecast From 2025 To 2033
Trending Insights

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels
BALLOON AORTIC VALVULOPLASTY DEVICES MARKET OVERVIEW
The global balloon aortic valvuloplasty devices market size in 2024 was estimated to be USD 0.43 billion, with projections to grow to USD 1.57 billion by 2033 at a CAGR of 15.55% during the forecast period.
A balloon aortic valvuloplasty (BAV) is a minimally invasive procedure used to treat aortic valve stenosis. Aortic valve stenosis is a narrowing of the aortic valve, which is located between the heart and the aorta. This narrowing can make it difficult for blood to flow out of the heart, which can lead to a number of symptoms, including shortness of breath, chest pain, and fatigue.
In a BAV procedure, a catheter is inserted into the groin and threaded up to the heart. A balloon is then inflated inside the narrowed valve, which helps to widen the valve opening. This allows blood to flow more easily out of the heart. BAV is a relatively safe procedure with a high success rate. However, it is not a permanent solution for aortic valve stenosis. In some cases, the valve may narrow again, and a repeat procedure may be necessary.
COVID-19 IMPACT
Pandemic Decreased the Market Demand
The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.
The COVID-19 pandemic has had a significant impact on the balloon aortic valvuloplasty devices market share. First, the pandemic has led to a decrease in the number of cardiac surgeries performed. This is because hospitals have had to prioritize resources for COVID-19 patients, and elective procedures such as BAV have been postponed or cancelled. As a result, the demand for balloon aortic valvuloplasty devices has decreased. Second, the pandemic has also led to supply chain disruptions. This has made it more difficult for hospitals to obtain balloon aortic valvuloplasty devices, which has further exacerbated the decline in demand. Third, the pandemic has also led to an increase in the cost of balloon aortic valvuloplasty devices. This is because the cost of manufacturing and shipping these devices has increased.
LATEST TRENDS
Development of new devices that are more effective and less invasive is expected to fuel the growth in the market
The development of new balloon aortic valvuloplasty devices is a rapidly evolving field, with researchers and engineers constantly developing new technologies to improve the effectiveness and reduce the invasiveness of these procedures. Some of the most promising new technologies in development include:
- Bioresorbable balloons and stents: These devices are made of materials that dissolve over time, leaving no foreign material in the body. This could reduce the risk of complications such as infection or rejection.
- Magnetically controlled balloons and stents: These devices can be moved around inside the heart using magnets, which could make it easier to insert them precisely and reduce the risk of damage to surrounding tissue.
- Tissue-engineered valves: These valves are made from the patient's own cells, so they are less likely to be rejected by the body. This could make them a more permanent solution for aortic valve stenosis.
In addition to these new technologies, researchers are also working to improve the design of existing balloon aortic valvuloplasty devices. For example, they are developing balloons and stents that are more flexible and durable, and that can be inserted through smaller incisions.
BALLOON AORTIC VALVULOPLASTY DEVICES MARKET SEGMENTATION
By Type
According to type, the market can be segmented into Balloon Diameter (mm) 18-22, Balloon Diameter (mm) 22-25, Balloon Diameter (mm) 25-28 and others.
By Application
Based on age, the market can be divided into Old Man, Middle-aged Person, Youth and Children.
DRIVING FACTORS
Increasing prevalence of aortic valve stenosis to foster the market growth
Aortic valve stenosis is a narrowing of the aortic valve, which is located between the heart and the aorta. This narrowing can make it difficult for blood to flow out of the heart, which can lead to a number of symptoms, including shortness of breath, chest pain, and fatigue. The prevalence of aortic valve stenosis is increasing due to a number of factors. The risk of developing aortic valve stenosis increases with age. Aortic valve stenosis is a common complication of other cardiovascular diseases, such as coronary artery disease and hypertension. Obesity is also a risk factor for aortic valve stenosis. The increasing prevalence of aortic valve stenosis is driving the market for balloon aortic valvuloplasty devices because BAV is a minimally invasive procedure that can be used to treat this condition. BAV is less invasive than traditional open-heart surgery, which makes it a more attractive option for patients.
Growing demand for minimally invasive procedures to result in the expansion of the market
There is a growing demand for minimally invasive procedures in all areas of medicine, including cardiology. This is because minimally invasive procedures offer a number of advantages over traditional open-heart surgery. Patients who undergo minimally invasive procedures typically have a shorter recovery time than those who undergo open-heart surgery. Minimally invasive procedures are associated with a lower risk of complications than open-heart surgery. Minimally invasive procedures often leave smaller scars than open-heart surgery. The growing demand for minimally invasive procedures is driving the market for balloon aortic valvuloplasty devices because BAV is a minimally invasive procedure that can be used to treat a number of heart conditions, including aortic valve stenosis.
RESTRAINING FACTORS
The high cost to hamper the market growth
The cost of BAV procedures can vary depending on a number of factors, including the type of device used, the experience of the surgeon, and the patient's insurance coverage. However, BAV procedures are typically more expensive than traditional open-heart surgery. The high cost of BAV procedures can be a barrier for some patients, especially those who do not have insurance or who have high deductibles
-
Request a Free sample to learn more about this report
BALLOON AORTIC VALVULOPLASTY DEVICES MARKET REGIONAL INSIGHTS
Asia Pacific to lead the market owing to aging population in the region
The Asia Pacific region has shown the highest balloon aortic valvuloplasty devices market growth. The Asia-Pacific region has a rapidly aging population, which is a major risk factor for aortic valve stenosis. Cardiovascular diseases are the leading cause of death in the Asia-Pacific region, and aortic valve stenosis is a common complication of these diseases.
KEY INDUSTRY PLAYERS
Key players are employing advanced technologies in order to stimulate further growth of the market
All the major players are motivated to offer superior and more advanced services in order to gain a competitive edge in the market. To increase their market presence, vendors are using a variety of techniques, including product launches, regional growth, strategic alliances, partnerships, mergers, and acquisitions.
List of Top Balloon Aortic Valvuloplasty Devices Companies
- BD (US)
- NuMED (US)
- Edwards Lifesciences (US)
- Venus Medtech (China)
- Balton Ltd. (UK)
REPORT COVERAGE
This report examines an understanding of the balloon aortic valvuloplasty devices market’s size, share, growth rate, segmentation by type, application, key players, and previous and current market scenarios. The report also collects the market’s precise data and forecasts by market experts. Also, it describes the study of this industry’s financial performance, investments, growth, innovation marks, and new product launches by the top companies and offers deep insights into the current market structure, competitive analysis based on key players, key driving forces, and restraints that affect the demand for growth, opportunities, and risks.
Furthermore, the post-COVID-19 pandemic’s effects on international market restrictions and a deep understanding of how the industry will recover, and strategies are also stated in the report. The competitive landscape has also been examined in detail to provide clarification of the competitive landscape.
This report also discloses the research based on methodologies that define price trend analysis of target companies, collection of data, statistics, target competitors, import-export, information, and previous years’ records based on market sales. Moreover, all the significant factors which influence the market such as small or medium business industry, macro-economic indicators, value chain analysis, and demand-side dynamics, with all the major business players have been explained in detail. This analysis is subject to modification if the key players and feasible analysis of market dynamics change.
Attributes | Details |
---|---|
Market Size Value In |
US$ 0.43 Billion in 2024 |
Market Size Value By |
US$ 1.57 Billion by 2033 |
Growth Rate |
CAGR of 15.55% from 2025 to 2033 |
Forecast Period |
2025-2033 |
Base Year |
2024 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
|
By Type
|
|
By Application
|
FAQs
The global balloon aortic valvuloplasty devices market is expected to reach USD 1.57 billion by 2033.
The global balloon aortic valvuloplasty devices market is expected to exhibit a CAGR of 15.55% by 2033.
The driving factors of the balloon aortic valvuloplasty devices market are increasing prevalence of aortic valve stenosis and growing demand for minimally invasive procedures.
The top companies operating in the balloon aortic valvuloplasty devices market are BD, NuMED, Edwards Lifesciences, Venus Medtech, Balton Ltd.